Cytoprotective Effect and Clinical Outcome of Perioperative Proesterone in Brain Tumors
NCT ID: NCT04414020
Last Updated: 2020-06-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
26 participants
INTERVENTIONAL
2020-06-01
2020-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Progesterone Administration on Severely Head Injured Patients
NCT06631547
Effect of Progesterone Therapy on Traumatic Subarachinoid Haemorrhage on Clinical Outcome and Resistive Vasculer Indices of Middle Cerebral Artery Transcranial Doppler
NCT04426487
Mgso4 as Neuroprotective in Post Traumatic Brain Injury
NCT04646876
Progesterone Treatment of Blunt Traumatic Brain Injury
NCT00048646
Progesterone for the Treatment of Traumatic Brain Injury III
NCT00822900
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Control group receiving conventional treatment without progesterone
No interventions assigned to this group
progesterone group
1mg pregesterone intramusculer given 7 days pre and post operative , Biopsy was achieved from brain tumor interface
Progesteron
intramusculer progesterone
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Progesteron
intramusculer progesterone
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Emergency craniotomy
20 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Minia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mina Maher
Principle investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine
Al Minyā, Abohelal, Egypt
Faculty of Medicine
Minya, Abohelal, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
623-4/2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.